Tag: Sulfate-3-glucuronyl paragloboside (SGPG)

Come Visit BUHLMANN at AMLI 2017- Booth #13

AMLI 2017 BUHLMANN Diagnostics Corp Booth: #13 August 13 - 16, 2017 Renaissance Stapleton Hotel | Denver, C0 LEARN MORE Click & Contact our AMLI 2017BUHLMANN Team Connect with our team ahead of time, learn more about the BÜHLMANN's Products and Solutions or schedule a meeting! Jennifer Stuart, Technical Sales Specialist JENNIFER STUART Technical Sales Specialist jls@buhlmannlabs.com

Higher sensitivity detecting anti-myelin-associatedglycoprotein (MAG) IgM autoantibody using antigen purified from human brain

BÜHLMANN Anti-MAG Autoantibodies ELISA: Jaskowski et al. Higher sensitivity detecting anti-myelin-associatedglycoprotein (MAG) IgM autoantibody using antigen purified from human brain. 8th International Congress of Neuroimmunology. October 15-19, 2006. Nagoya, Japan. Highlights from this Publication "The MAG EIA showed excellent sensitivity (97.5%) when compared to Western blot and has the advantages of being objective...and identifying [subjects] that

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Tag: Sulfate-3-glucuronyl paragloboside (SGPG)

Come Visit BUHLMANN at AMLI 2017- Booth #13

Higher sensitivity detecting anti-myelin-associatedglycoprotein (MAG) IgM autoantibody using antigen purified from human brain

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US